A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination

In this report, we examine the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This is a case of a 62-year-old female who received the first dose of COVID-19 vaccine in J...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Yafeai, Zaki, Horn, Benjamin Joesph M, Terraccaine, William, Jose, Alvin, Krishnan, Prathik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010006/
https://www.ncbi.nlm.nih.gov/pubmed/35444915
http://dx.doi.org/10.7759/cureus.23162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010006/
https://www.ncbi.nlm.nih.gov/pubmed/35444915
http://dx.doi.org/10.7759/cureus.23162

Ejemplares similares